2A3Z

ICD-11 MMS 2026-01

Myelodysplastic syndromes, unspecified

Exclusions from above levels

  • 2A60.2 – Therapy-related myeloid neoplasms
  • 3A70.10 – Drug-induced aplastic anaemia
  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
Show allHide
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

  • 2A30 – Refractory anaemia
  • 2A31 – Refractory neutropaenia
  • 2A32 – Refractory thrombocytopenia
  • 2A33 – Refractory anaemia with ring sideroblasts
  • 2A34 – Refractory cytopenia with multi-lineage dysplasia
  • 2A35 – Refractory anaemia with excess of blasts
  • 2A36 – Myelodysplastic syndrome with isolated del(5q)
  • 2A37 – Myelodysplastic syndrome, unclassifiable
  • 2A38 – Refractory cytopenia of childhood
  • 2A3Y – Other specified myelodysplastic syndromes

Foundation entity

Myelodysplastic syndromes – http://id.who.int/icd/entity/1147802348

Allowed postcoordination axes

Part of: 02: Neoplasms